Industry: Chemical & Material
Published Date: 2025-02-16
Pages: 116 Pages
Report ld: 3972209
Request Sample
Customized Report
EUV Pellicle Market Size(US$)

CAGR 2025-2031
8.6%
Market Size,2031
USD 171
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Valued at US$ 104 million in 2024, the global EUV Pellicle market is forecast to reach US$ 171 million by 2030, at a CAGR of 8.6% during the forecast period.
In a typical semiconductor process, a thin protective film is usually placed on the surface of the photomask to protect it from contaminants. This thin film, called a pellicle, prevents undesirable conditions or defects in the wafer circuit pattern, thereby protecting the IC chip from potential damage. In addition, the mask protective film is also a consumable that needs to be replaced regularly, and because the light source wavelength of EUV lithography equipment is shorter, the protective film needs to be thinner to increase light transmittance.
Initially, the film was a single-layer structure with a core layer made of polysilicon. Since 2021, EUV pellicle have adopted composite materials. Its key components now consist of alternating molybdenum disilicide (MoSi₂) and silicon (Si) layers to form a multi-layer structure. EUV transmittance (EUVT) is a key performance indicator of EUV pellicle. The transition from a single-layer structure to a multi-layer structure has increased EUVT from about 82% to about 90%. The next generation of film technology will go beyond structural changes (from single-layer to multi-layer) and introduce material advances, leading to the emergence of CNT pellicle.
Driven by advances in artificial intelligence (AI) and computing technology, the semiconductor industry's demand for advanced chips continues to grow, with the fastest growth in chips below 7nm manufactured using EUV technology. In advanced processes of 7nm and below, the pattern size on the mask may be only tens of nanometers, which places extremely strict requirements on the uniformity and defect control of the Pellicle. The next generation of high-power EUV lithography machines operates at more than 500W, and EUV films are needed to protect the photomask from particle contamination during chip production.
In recent years, the phenomenon of chipmakers adopting extreme ultraviolet (EUV) processes in their advanced chip manufacturing is rapidly increasing. To meet this growing demand, many companies are developing protective films for EUV processes.
ASML launched its first EUV pellicle in 2019 and licensed the technology to Mitsui Chemicals, which began mass sales in 2021. Since then, ASML has made improvements to its pellicle. It is reported that Mitsui Chemicals' next-generation CNT pellicle production facility will be completed by the end of 2025.
In 2021, South Korean company S&S Tech developed a pellicle with a transmittance of more than 90%. FST's EUV pellicle is still in the development stage.
Canatu has been working with Imec since 2015 to develop CNT pellicle to meet performance targets such as life and transmittance, thermal durability, permeability and strength.
In terms of production side, this report researches the EUV Pellicle production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of EUV Pellicle by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for EUV Pellicle, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of EUV Pellicle, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for EUV Pellicle, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the EUV Pellicle sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global EUV Pellicle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for EUV Pellicle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mitsui Chemicals, S&S Tech, Canatu, TSMC, FST, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: EUV Pellicle production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of EUV Pellicle in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of EUV Pellicle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EUV Pellicle sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 EUV Pellicle Product Introduction
1.2 Market by Type
1.2.1 Global EUV Pellicle Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ≥90% transmittance
1.2.3 <90% transmittance
1.3 Market by Application
1.3.1 Global EUV Pellicle Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 IDM
1.3.3 Foundry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global EUV Pellicle Production
2.1 Global EUV Pellicle Production Capacity (2020-2031)
2.2 Global EUV Pellicle Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global EUV Pellicle Production by Region (2020-2031)
2.3.2 Global EUV Pellicle Production Market Share by Region (2020-2031)
2.4 Europe
2.5 Japan
2.6 South Korea
2.7 China Taiwan
3 Executive Summary
3.1 Global EUV Pellicle Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global EUV Pellicle Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global EUV Pellicle Revenue by Region (2020-2031)
3.2.3 Global EUV Pellicle Revenue Market Share by Region (2020-2031)
3.3 Global EUV Pellicle Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global EUV Pellicle Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global EUV Pellicle Sales by Region (2020-2031)
3.4.3 Global EUV Pellicle Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global EUV Pellicle Sales by Manufacturers (2020-2025)
4.1.2 Global EUV Pellicle Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of EUV Pellicle in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global EUV Pellicle Revenue by Manufacturers (2020-2025)
4.2.2 Global EUV Pellicle Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by EUV Pellicle Revenue in 2024
4.3 Global EUV Pellicle Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of EUV Pellicle, Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global EUV Pellicle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of EUV Pellicle, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of EUV Pellicle, Product Offered and Application
4.8 Global Key Manufacturers of EUV Pellicle, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global EUV Pellicle Historical Sales by Type (2020-2025)
5.1.2 Global EUV Pellicle Forecasted Sales by Type (2026-2031)
5.1.3 Global EUV Pellicle Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global EUV Pellicle Historical Revenue by Type (2020-2025)
5.2.2 Global EUV Pellicle Forecasted Revenue by Type (2026-2031)
5.2.3 Global EUV Pellicle Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global EUV Pellicle Price by Type (2020-2025)
5.3.2 Global EUV Pellicle Price Forecast by Type (2026-2031)
6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global EUV Pellicle Historical Sales by Application (2020-2025)
6.1.2 Global EUV Pellicle Forecasted Sales by Application (2026-2031)
6.1.3 Global EUV Pellicle Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global EUV Pellicle Historical Revenue by Application (2020-2025)
6.2.2 Global EUV Pellicle Forecasted Revenue by Application (2026-2031)
6.2.3 Global EUV Pellicle Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global EUV Pellicle Price by Application (2020-2025)
6.3.2 Global EUV Pellicle Price Forecast by Application (2026-2031)
7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada EUV Pellicle Sales by Type (2020-2031)
7.1.2 US & Canada EUV Pellicle Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada EUV Pellicle Sales by Application (2020-2031)
7.2.2 US & Canada EUV Pellicle Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada EUV Pellicle Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada EUV Pellicle Revenue by Country (2020-2031)
7.3.3 US & Canada EUV Pellicle Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe EUV Pellicle Sales by Type (2020-2031)
8.1.2 Europe EUV Pellicle Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe EUV Pellicle Sales by Application (2020-2031)
8.2.2 Europe EUV Pellicle Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe EUV Pellicle Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe EUV Pellicle Sales by Country (2020-2031)
8.3.3 Europe EUV Pellicle Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Market Size by Type
9.1.1 China EUV Pellicle Sales by Type (2020-2031)
9.1.2 China EUV Pellicle Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China EUV Pellicle Sales by Application (2020-2031)
9.2.2 China EUV Pellicle Revenue by Application (2020-2031)
10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia EUV Pellicle Sales by Type (2020-2031)
10.1.2 Asia EUV Pellicle Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia EUV Pellicle Sales by Application (2020-2031)
10.2.2 Asia EUV Pellicle Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia EUV Pellicle Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia EUV Pellicle Revenue by Region (2020-2031)
10.3.3 Asia EUV Pellicle Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America EUV Pellicle Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America EUV Pellicle Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America EUV Pellicle Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America EUV Pellicle Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America EUV Pellicle Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America EUV Pellicle Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America EUV Pellicle Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Mitsui Chemicals
12.1.1 Mitsui Chemicals Corporation Information
12.1.2 Mitsui Chemicals Overview
12.1.3 Mitsui Chemicals EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 Mitsui Chemicals EUV Pellicle Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Mitsui Chemicals Recent Developments
12.2 S&S Tech
12.2.1 S&S Tech Corporation Information
12.2.2 S&S Tech Overview
12.2.3 S&S Tech EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 S&S Tech EUV Pellicle Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 S&S Tech Recent Developments
12.3 Canatu
12.3.1 Canatu Corporation Information
12.3.2 Canatu Overview
12.3.3 Canatu EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 Canatu EUV Pellicle Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Canatu Recent Developments
12.4 TSMC
12.4.1 TSMC Corporation Information
12.4.2 TSMC Overview
12.4.3 TSMC EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 TSMC EUV Pellicle Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 TSMC Recent Developments
12.5 FST
12.5.1 FST Corporation Information
12.5.2 FST Overview
12.5.3 FST EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 FST EUV Pellicle Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 FST Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 EUV Pellicle Industry Chain Analysis
13.2 EUV Pellicle Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 EUV Pellicle Production Mode & Process
13.4 EUV Pellicle Sales and Marketing
13.4.1 EUV Pellicle Sales Channels
13.4.2 EUV Pellicle Distributors
13.5 EUV Pellicle Customers
14 EUV Pellicle Market Dynamics
14.1 EUV Pellicle Industry Trends
14.2 EUV Pellicle Market Drivers
14.3 EUV Pellicle Market Challenges
14.4 EUV Pellicle Market Restraints
15 Key Findings in the Global EUV Pellicle Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global EUV Pellicle market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 75
USD 4250.00
(Single User License)
The global market for EUV Pellicle was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 84
USD 3950.00
(Single User License)
The global EUV Pellicle market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 119
USD 2900.00
(Single User License)
The global EUV Pellicle market size was US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 71
USD 4250.00
(Single User License)
The global EUV Pellicle market is projected to grow from US$ 78.8 million in 2024 to US$ 171 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 130
USD 4900.00
(Single User License)
The global market for EUV Pellicle was estimated to be worth US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-02-16
Pages: 85
USD 3950.00
(Single User License)
The global market for EUV Pellicle was valued at US$ 78.8 million in the year 2024 and is projected to reach a revised size of US$ 171 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published Date: 2025-02-16
Pages: 84
USD 2900.00
(Single User License)
The global market for EUV Pellicle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 117
USD 3950.00
(Single User License)
The global EUV Pellicle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 97
USD 2900.00
(Single User License)
The global EUV Pellicle market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 75
The global market for EUV Pellicle was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-06
Pages: 84
The global EUV Pellicle market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-06
Pages: 119
The global EUV Pellicle market size was US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 71
The global EUV Pellicle market is projected to grow from US$ 78.8 million in 2024 to US$ 171 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 130
The global market for EUV Pellicle was estimated to be worth US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-02-16
Pages: 85
The global market for EUV Pellicle was valued at US$ 78.8 million in the year 2024 and is projected to reach a revised size of US$ 171 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published: 2025-02-16
Pages: 84
The global market for EUV Pellicle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 117
The global EUV Pellicle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now